International Review of Ophthalmology ›› 2022, Vol. 46 ›› Issue (2): 104-112.doi: 10.3760/ cma.j.issn.1673-5803.2022.02.002

Previous Articles     Next Articles

Phacoemulsification for the treatment of glaucoma

Zhang Ruixue, He Yuan   

  1. Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Medical University, Xi’an 710038, China
  • Received:2021-03-21 Online:2022-04-22 Published:2022-04-24
  • Contact: He Yuan, Email: openji7127@hotmail.com
  • Supported by:
    National Natural Science Foundation of China (82070964); The Science Fund for Distinguished Young Scholars in Shaanxi Province (2022JC-60); Youth Project of the Second Affiliated Hospital of Xi 'an Medical university (22KY0114)  



Abstract: Phacoemulsification (Phaco) in the treatment of patients with primary angle closure glaucoma (PACG), phacogenic glaucoma and primary open angle glaucoma (POAG) combined with cataract has a certain  effect of reducing  intraocular pressure and increasing the depth of the anterior chamber. For PACG patients with cataract, Phaco is more effective than laser peripheral iridotomy (LPI). The indications and intraocular pressure lowering effects of Phaco alone and Phaco+goniosynechialysis, Phaco+trabeculectomy and trabeculectomy were analyzed. The postoperative efficacy was different according to preoperative anterior chamber angle, intraocular pressure, the amount of intraocular pressure lowering medications and the damage of optic nerve in fundus. (Int Rev Ophthalmol, 2022, 46:  104-112)


Key words: phacoemulsification, primary angle closure glaucoma